YGALO Trademark

Trademark Overview

On Thursday, November 19, 2015, a trademark application was filed for YGALO with the United States Patent and Trademark Office. The USPTO has given the YGALO trademark a serial number of 79179189. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 21, 2023. This trademark is owned by Oncopeptides AB. The YGALO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma
ygalo

General Information

Serial Number79179189
Word MarkYGALO
Filing DateThursday, November 19, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 21, 2023
Registration Number5116441
Registration DateTuesday, January 10, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements

Goods and Servicespharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma
Translation of Words in MarkThe wording "YGALO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncopeptides AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameOncopeptides AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameOncopeptides AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, April 2, 2024INVALIDATION PROCESSED
Thursday, March 21, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 21, 2023CANCELLED SECTION 71
Monday, January 10, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, September 21, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 28, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 12, 2017FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 12, 2017FINAL DISPOSITION PROCESSED
Monday, April 10, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 10, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 5, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 1, 2016REFUSAL PROCESSED BY IB
Tuesday, March 15, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 15, 2016REFUSAL PROCESSED BY MPU
Tuesday, March 15, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 14, 2016NON-FINAL ACTION WRITTEN
Sunday, March 13, 2016ASSIGNED TO EXAMINER
Tuesday, January 5, 2016APPLICATION FILING RECEIPT MAILED
Thursday, December 31, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 29, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ygalo neoplastic diseases multiple myeloma cancer treatment medicinal veterinary preparations pharmaceutical